average monthly price glp-1 drugs 2025 Patients Face New Barriers for How Employers Can Manage GLP-1
Description
A new equation to estimate glomerular filtration rate
Medicare does cover GLP-1s for FDA-approved uses other than weight loss, including type 2 diabetes, reducing cardiovascular risk and obstructive sleep apnea
Biosimilar semaglutide development is advancing toward regulatory review by multiple pharmaceutical companies, with FDA biosimilar pathways potentially enabling lower-cost GLP-1 access within the forecast period
That limited access
Sometimes, these promotions look almost identical to ads for beauty products or fitness supplements
Suryadevara, V
